Secukinumab

Category: Arthritis



Secukinumab Overview

Secukinumab, trade name Cosentyx, is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by Novartis for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis.[1][2] It inhibits a member of the cytokine family, interleukin 17A.[1] Contents 1 Medical uses 2 Adverse effects 3 Pharmacology 4 Chemistry 5 History 6 References Medical uses It is used to treat psoriasis, ...

Read more Secukinumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Secukinumab

Recent Secukinumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Secukinumab
  • Injection: 150mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Secukinumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA